1. Home
  2. REXR vs EXAS Comparison

REXR vs EXAS Comparison

Compare REXR & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rexford Industrial Realty Inc.

REXR

Rexford Industrial Realty Inc.

HOLD

Current Price

$41.17

Market Cap

9.7B

Sector

Real Estate

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.50

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REXR
EXAS
Founded
2013
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
11.0B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
REXR
EXAS
Price
$41.17
$101.50
Analyst Decision
Hold
Buy
Analyst Count
11
20
Target Price
$43.10
$77.94
AVG Volume (30 Days)
2.2M
10.8M
Earning Date
02-04-2026
11-03-2025
Dividend Yield
4.17%
N/A
EPS Growth
15.85
N/A
EPS
1.43
N/A
Revenue
$997,931,000.00
$3,082,033,000.00
Revenue This Year
$9.35
$19.40
Revenue Next Year
$3.81
$13.51
P/E Ratio
$28.97
N/A
Revenue Growth
10.40
14.47
52 Week Low
$29.68
$38.81
52 Week High
$44.38
$101.95

Technical Indicators

Market Signals
Indicator
REXR
EXAS
Relative Strength Index (RSI) 50.53 89.65
Support Level $39.53 $100.95
Resistance Level $41.96 $101.95
Average True Range (ATR) 0.76 0.34
MACD 0.05 -1.01
Stochastic Oscillator 65.35 60.00

Price Performance

Historical Comparison
REXR
EXAS

About REXR Rexford Industrial Realty Inc.

Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: